2m 2m 2m 2m 2m 2m 2m
FOGHORN THERAP (FHTX)
NASDAQ
$2.08+$0.18 (+9.47%)
Price as of Nov 11, 2026 7:35 PM EST- $112.8MMarket Cap
- -57.21%1-Year Change
- BiotechnologyIndustry
FOGHORN THERAP (FHTX)
$2.08+$0.18 (+9.47%)
FHTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.90 | ||
Change | -$0.14 (-6.86%) | ||
Open | $2.02 | ||
High | $2.03 | ||
Low | $1.84 | ||
Previous Close | $2.04 | ||
Volume | 719,281 | ||
30-Day Average Volume | 698,821 | ||
1-Week Change | -10.80% | ||
1-Month Change | -5.00% | ||
1-Year Change | -57.21% | ||
3-Year Change | -41.18% | ||
5-Year Change | -86.26% | ||
Fundamentals | |||
Shares Outstanding | 59.4M | ||
Total Assets | $191.0M | ||
Market Cap | $112.8M | ||
Enterprise Value | $32.5M | ||
Period: QTR TTM FY | |||
Revenue | $83.5M | ||
Net Income | $58.1M | ||
Free Cash Flow | -$18.3M | ||
EBIT | $58.1M | ||
EBITDA | $58.4M | ||
Net Working Capital | $121.0M | ||
EPS | $0.80 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | 0 | ||
P/B | -8 | ||
P/E | 2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -6 | ||
Price/Operating Cash Flow | -6 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue